Veru, Inc. (VERU)
2.61
-0.03
(-1.14%)
USD |
NASDAQ |
Aug 24, 16:00
2.61
0.00 (0.00%)
After-Hours: 20:00
Veru EPS Diluted (Quarterly) : -0.3032 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3032 |
| March 31, 2026 | -0.1342 |
| December 31, 2025 | -0.2625 |
| September 30, 2025 | 0.089 |
| June 30, 2025 | -0.5003 |
| March 31, 2025 | -0.054 |
| December 31, 2024 | -0.3239 |
| September 30, 2024 | -0.5828 |
| June 30, 2024 | -0.7493 |
| March 31, 2024 | -0.6849 |
| December 31, 2023 | -0.8226 |
| September 30, 2023 | -0.1183 |
| June 30, 2023 | -0.0755 |
| March 31, 2023 | -4.18 |
| December 31, 2022 | -4.805 |
| September 30, 2022 | -5.107 |
| June 30, 2022 | -0.2771 |
| March 31, 2022 | -0.1771 |
| December 31, 2021 | -0.0797 |
| September 30, 2021 | -0.0538 |
| June 30, 2021 | -0.0338 |
| March 31, 2021 | -0.0379 |
| December 31, 2020 | 0.2273 |
| September 30, 2020 | -0.1694 |
| June 30, 2020 | -0.0453 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0124 |
| December 31, 2019 | -0.0508 |
| September 30, 2019 | -0.0471 |
| June 30, 2019 | -0.0441 |
| March 31, 2019 | -0.0643 |
| December 31, 2018 | -0.0344 |
| September 30, 2018 | -0.1436 |
| June 30, 2018 | -0.15 |
| March 31, 2018 | -0.718 |
| December 31, 2017 | -0.8009 |
| September 30, 2017 | -1.027 |
| June 30, 2017 | -0.03 |
| March 31, 2017 | -0.06 |
| December 31, 2016 | -0.04 |
| September 30, 2016 | -0.06 |
| June 30, 2016 | 0.02 |
| March 31, 2016 | 0.0012 |
| December 31, 2015 | 0.05 |
| September 30, 2015 | 0.02 |
| June 30, 2015 | 0.04 |
| March 31, 2015 | 0.06 |
| December 31, 2014 | 0.03 |
| September 30, 2014 | -0.02 |
| June 30, 2014 | 0.04 |
| March 31, 2014 | 0.01 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
| Lexicon Pharmaceuticals, Inc. | -0.0726 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.988M |
| Total Expenses (Quarterly) | 6.988M |
| Enterprise Value | 21.90M |
| Earnings Yield | -23.41% |
| Normalized Earnings Yield | -28.50 |